Risk of bladder cancer death in patients younger than 50 with non-muscle-invasive and muscle-invasive bladder cancer

References

• Swedish National Quality Register for Bladder and Urinary Tract Cancer (SNRUBC) [Internet]. 2019. Available from: https://statistik.incanet.se/Urinblasecancer/.
   Google Scholar
• Katafigiotis I, Sfoungaristos S, Martini A, et al. Bladder cancer to patients younger than 30 years: a retrospective study and review of the literature.Urologia]. 2017;84(4):231–235.
   PubMed Web of Science ®Google Scholar
• Lara J, Brunson A, Keegan TH, et al. Determinants of survival in adolescents and young adults with urothelial bladder cancer: results from the California cancer registry. J Urol. 2016;196(5):1378–1382.
   PubMed Web of Science ®Google Scholar
• Janisch F, Yu H, Vetterlein MW, et al. Do younger patients with muscle-invasive bladder cancer have better outcomes?J Clin Med. 2019;8(9):1–10.
   Web of Science ®Google Scholar
• de la Calle CM, WashingtonSL, LonerganPE, et al. Bladder cancer in patients younger than 40 years: outcomes from the national cancer database. World J Urol. 2021;39(6):1911–1916.
   PubMed Web of Science ®Google Scholar
• Wang ZH, Li YY, Hu ZQ, et al. Does urothelial cancer of bladder behave differently in young patients? Chin Med J. 2012;125(15):2643–2648.
   PubMed Web of Science ®Google Scholar
• Nilbert M, Bläckberg M, Ceberg J, et al. Diagnostic pathway efficacy for urinary tract cancer: population-based outcome of standardized evaluation for macroscopic haematuria. Scand J Urol. 2018;52(4):237–243.
   PubMed Web of Science ®Google Scholar
• Sylvester RJ, Rodríguez O, Hernández V, et al. European association of urology (EAU) prognostic factor risk groups for non–muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC guidelines panel[formula presented]. Eur Urol. 2021;79(4):480–488.
   PubMed Web of Science ®Google Scholar
• Haggstrom C, Liedberg F, Hagberg O, et al. Cohort profile: the swedish national register of urinary bladder cancer (SNRUBC) and the bladder cancerData Base Sweden (BladderBaSe)). BMJ Open. 2017;7(9):e016606.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, et al. The swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24(11):659–667.
   PubMed Web of Science ®Google Scholar
• Malmström PU. Time to abandon testing for microscopic haematuria in adults? Br Med J. 2003;326(7393):813–815.
   PubMed Web of Science ®Google Scholar
• Månsson Å, Anderson H, Colleen S. Time lag to diagnosis of bladder cancer-influence of psychosocial parameters and level of health-care provision. Scand J Urol Nephrol. 1993;27(3):363–369.
   PubMed Web of Science ®Google Scholar
• Textor J, van der Zander B, Gilthorpe MK, et al. Robust causal inference using directed acyclic graphs: the R package “dagitty. Int J Epidemiol. 2016;45(6):1887–1894.
   PubMed Web of Science ®Google Scholar
• Jiang DM, Gupta S, Kitchlu AK, et al. Defining cisplatin eligibility in patients with muscle-invasive bladder cancer. Nat Rev Urol. 2021;18(2):104–114.
   PubMed Web of Science ®Google Scholar
• Witjes JA, Bruins HM, Cathomas R, et al. European association of urology guidelines on muscle-invasive and metastatic bladder cancer: Summary of the 2020 guidelines [internet. Eur Urol. 2021;79(1):82–104.
   PubMed Web of Science ®Google Scholar
• Canter D, Viterbo R, Kutikov A, et al. Baseline renal function status limits patient eligibility to receive perioperative chemotherapy for invasive bladder cancer and is minimally affected by radical cystectomy. Urology. 2011;77(1):160–165.
   PubMed Web of Science ®Google Scholar
• Feng H, Zhang W, Li J, et al. Different patterns in the prognostic value of age for bladder cancer-specific survival depending on tumor stages. Am J Cancer Res. 2015;5(6):2090–2097.
   PubMed Web of Science ®Google Scholar
• Tian Z, Meng L, Wang X, et al. Young age increases the risk of lymph-node metastasis in patients with muscle-invasive bladder urothelial carcinoma. BMC Cancer. 2020;20(1):1–6.
   Web of Science ®Google Scholar
• Kirkali Z, Chan T, Manoharan M, et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology. 2005;66(6):4–34.
   PubMed Web of Science ®Google Scholar
• Telli O, Sarici H, Ozgur BC, et al. Urothelial cancer of bladder in young versus older adults: clinical and pathological characteristics and outcomes. Kaohsiung J Med Sci. 2014;30(9):466–470.
   PubMed Web of Science ®Google Scholar
• Shelekhova KV, Krykow KA, Mescherjakov IA, et al. Molecular pathologic subtyping of urothelial bladder carcinoma in young patients. Int J Surg Pathol. 2019;27(5):483–491.
   PubMed Web of Science ®Google Scholar
• Sun X, Hoadley KA, Kim WY, et al. Age at diagnosis, obesity, smoking, and molecular subtypes in muscle-invasive bladder cancer. Cancer Causes Control. 2017;28(6):539–544.
   PubMed Web of Science ®Google Scholar
• Ward DG, Arnold R, Bryan RT. Molecular subtypes of T1 bladder cancer: biomolecular characteristics versus clinical utility [internet]. Eur Urol. 2020;78(4):538–539.
   PubMed Web of Science ®Google Scholar
• Lian J, Yue Y, Yu W, et al. Immunosenescence: a key player in cancer development [internet]. J Hematol Oncol. 2020;13: 1–18.
   PubMed Web of Science ®Google Scholar
• Andreassen BK, Grimsrud TK, Haug ES. Bladder cancer survival: women better off in the long run. Eur J Cancer. 2018;95:52–58.
   PubMed Web of Science ®Google Scholar
• Cumberbatch MGK, Jubber I, Black PC, et al. Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018. Eur Urol. 2018;74(6):784–795.
   PubMed Web of Science ®Google Scholar
• Bryan RT, Evans T, Dunn JA, et al. A comparative analysis of the influence of gender, pathway delays, and risk factor exposures on the long-term outcomes of bladder cancer. Eur Urol Focus. 2015;1(1):82–89.
   PubMedGoogle Scholar
• Foxman B. Urinary tract infection in postmenopausal women. Curr Infect Dis Rep. 1999;1(4):367–370.
   PubMedGoogle Scholar